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Necrotizing ulcerative gingivitis (NUG) is an acute and occasionally
 
recurrent infection of complex aetiology 
which is characterised
 
by the sudden occurrence of gingival pain, necrosis of interdental
 
tissue, and 
bleeding.
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The bacterial flora develops as the result of an altered host
 
response, especially in teenagers and young 
adults. Precipitating
 
factors reported include: stress, smoking, poor dietary habits,
 
and oral hygiene.
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A 19-year-old male presented with a 1 day history of general
 
malaise, halitosis, foul taste in the mouth, and 
painful upper/lower
 
left jaws. He was a non-smoker and he had no other past medical
 
history of note.
 
 
During the examination, the patient admitted to having used
 
"Ecstasy" (3, 4-
methylenedioxymethamphetamine, MDMA) as a recreational
 
drug 3 days before the onset of symptoms 
and to storing the
 
drug next to the site of the periodontal necrosis. Local drug
 
induced necrotising gingivitis 
was diagnosed (figs 1 and 2).
 
A differential diagnosis of desquamative gingivitis and herpetic
 
gingivostomatitis was also made.
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Figure 1 Marginal gingival necrosis in upper and lower left jaws related to use of Ecstasy (MDMA). 
Note that plaque control is rather good in this patient.  
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Figure 2 Close up of ulceration. Note characteristic gingival crater defects and marginal 
pseudomembranes.  
 
  The patient was advised to stop using MDMA. Treatment included
 
surgical debridement—scaling and 
root planing—of
 
the teeth involved with chlorhexidine 0.20% irrigation and 5
 
days oral amoxicillin/clavulanic 
acid 875+125 mg every 8h and
 
metronidazole 500 mg every 8h. The recovery was satisfactory.
 
 
Several cases of NUG have been associated with the consumption
 
of MDMA. The possible mechanism 
might be related to a direct
 
contact between the drug and oral mucosa, the acid components
 
of the tablet 
and the dry mouth induced by MDMA.
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In some patients, NUG can progress to necrotising periodontitis
 
and even to necrotising stomatitis, 
potentially leading to a
 
fulminating orofacial infection known as noma or cancrum oris.
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